close-icon

MHQ: Clinical IntelligencePowered by SurvivorNet

  • health-panel

    Medical History

  • clinical-trial

    Clinical Trials

    ?
Prefer to talk instead of typing?
close-icon

Answers offered are informational and do not constitute medical advice. Learn more

close-icon
Medical History

Review your patient’s information.

What is your gender?

What is your age?

close-icon
Clinical Trials

clinical-icon

filter

Clear List

Ask me anything about your health...

I’m listening

thinking

responding

close-icon close-icon
close-icon
close-icon
close-icon
left-icon Back to Results

Dr. Philip Rubin

location-icon

New York, NY

LOCATION OF PRACTICE
Bronxcare Hospital Center
MEDICAL Specialty:

Anemia, Thalassemia, Thrombocytosis



GPO BOX 27638, NEW YORK, NY, 100877638
6300 8TH AVE, BROOKLYN, NY, 112204718
NPI Number
1336253053
ABOUT

Philip Rubin, MD, is a hematologist in Brooklyn, NY. He has 43 years of experience and is board certified in Hematology, frequently treating conditions like Thalassemia, Thrombocytosis, and Anemia. Rubin graduated from the University of Alaska / Anchorage Campus and is affiliated with BronxCare Hospital Center.

Dr. Philip Rubin profile image

Published Articles

Endothelial KLF4 depletion drives age-related neurovascular dysfunction and neuropsychiatric impairment.- 2026 Jun 23
Acute blood pressure reduction exceeding safety and autoregulatory limits following rapid-acting antihypertensives for hypertensive urgency.- 2026 Jul 1
A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules.- 2026 Apr 2
Single-cell dynamics of genome-nucleolus interactions captured by nucleolar laser microdissection (NoLMseq).- 2025 Dec 17
Outcome Analysis of Reduction and Nonreduction Dismembered Pyeloplasty in Ureteropelvic Junction Obstruction: a Large, Multicenter, Retrospective, Comparative Study.- 2026 Feb
A double-negative prostate cancer subtype is vulnerable to SWI/SNF-targeting degrader molecules.- 2025 Sep 3
Discovery of potent and selective inhibitors of human NLRP3 with a novel mechanism of action.- 2025 Nov 3
Epicardial Lead Pacer Wire Migration Causing Endocarditis in an Orthotopic Heart Transplant Patient.- 2024 Oct
Longevity biotechnology: bridging AI, biomarkers, geroscience and clinical applications for healthy longevity.- 2024 Oct 16
Search for Leptonic Decays of Dark Photons at NA62.- 2024 Sep 13

Clinical Trials

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
NVD-003 in the Treatment of Congenital Pseudarthrosis of the Tibia
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Other Specialists treating Anemia, Thalassemia, Thrombocytosis in New York, NY

See All Doctors

Dr. Jennifer Ratner

Specialty: Anemia, Anemia and Iron Deficiency Screening, Erythropoietin Test

My Resources
location-icon

New York-Presbyterian Hospital

My Resources

Dr. Caitlin Gribbin

Specialty: Acquired Hemolytic Anemia, Anemia, Bleeding Disorders

My Resources
location-icon

New York-Presbyterian Hospital

My Resources

Dr. Dominder Kaur

Specialty: Sickle Cell Disease, Sickle Cell Hemoglobin SS Disease, Anemia

My Resources
My Resources

Dr. Katherine Bell-McGuinn

Specialty: Anemia, Bladder Cancer, Cervical Cancer

My Resources
My Resources

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider